Albany Capital (Australia) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Investments
-
23
- Portfolio
-
9
- Exits
-
11
Albany Capital (Australia) General Information
Company Description
Albany Capital is a venture capital firm based in Albany, Australia. The firm prefers to invest in companies operating in the technology, health, sustainability, and digital sectors.
Business Details
Website
www.albanycapital.com.auInvestor Status
Primary Investor Type
Corporate Office
- Albany, Western Australia
- Australia
Albany Capital (Australia) Investments (23)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Sanguine Biosciences | 15-Aug-2024 | Later Stage VC | Other Healthcare Technology Systems | Generating Revenue | ||
| Animoca Brands | 31-Mar-2023 | Entertainment Software | Generating Revenue | |||
| Sanguine Biosciences | 09-Jan-2023 | Other Healthcare Technology Systems | Generating Revenue | |||
| Protein Evolution | 31-May-2022 | Specialty Chemicals | Generating Revenue | |||
| Jump Technologies | 04-May-2022 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Sherlock Biosciences | 28-Feb-2022 | Diagnostic Equipment | Generating Revenue | |||
| Access Telehealth | 01-Nov-2021 | Clinics/Outpatient Services | Generating Revenue | |||
| Stride Health | 26-Oct-2021 | Other Insurance | Generating Revenue | |||
| AgBiome | 14-Sep-2021 | Later Stage VC | Agricultural Chemicals | Generating Revenue | ||
| identifeye HEALTH | 20-Apr-2021 | Early Stage VC | Monitoring Equipment | Generating Revenue |
Albany Capital (Australia) Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Stride Health | 08-Jul-2026 | Buyout/LBO | |
| Liminal Sciences | 27-Jun-2026 | ||
| OrphAI Therapeutics | 18-May-2026 | ||
| Butterfly Network (Burlington) | 30-Jan-2025 | ||
| Sherlock Biosciences | 19-Dec-2024 | ||
| AgBiome | 11-Apr-2024 | ||
| Bluesight | 17-Jul-2023 | ||
| PFS Genomics | 03-May-2021 | ||
| Decipher Urologic Cancers | 12-Mar-2021 | Merger/Acquisition | |
| Celsee | 01-Apr-2020 | Merger/Acquisition |
Albany Capital (Australia) Investments by Industry, Year, and Region
Albany Capital (Australia) Co-Investors (18)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Catalio Capital Management | 2 |
|
|
||
| BroadOak Capital Partners |
|
|
|||
| Collaborative Fund |
|
|
|||
| Jenner |
|
|
|||
| Wexford Capital |
|
|
Albany Capital (Australia) FAQs
-
What is Albany Capital (Australia)?
Albany Capital is a venture capital firm based in Albany, Australia.
-
Where is Albany Capital (Australia) headquartered?
Albany Capital (Australia) is headquartered in Albany, Australia.
-
How many investments has Albany Capital (Australia) made?
Albany Capital (Australia) has made 23 investments.
-
What has Albany Capital (Australia) invested in?
Albany Capital (Australia) has made numerous investments in companies like Sanguine Biosciences, Animoca Brands, and Protein Evolution within the Healthcare Technology Systems, Entertainment Software, and Specialty Chemicals industries.
-
What has Albany Capital (Australia) invested in recently?
Albany Capital (Australia)'s latest investment was on 15-Aug-2024 in Sanguine Biosciences, a company within the Healthcare Technology Systems industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process